Robust and resilient supply ecosystems are essential to support the fight against HIV, tuberculosis (TB) and malaria. COVID-19 has put enormous pressure on health systems worldwide, with a clear need to strengthen and accelerate the development of su...
While the Global Fund’s assessment of health product supply disruption has been moderate overall during the past 18 months, supply challenges are increasing as a result of growing international freight capacity constraints. Those challenges are likel...
The Global Fund and Unitaid are inviting manufacturers of diagnostic products to submit an Expression of Interest (EoI) to have their products evaluated by the Expert Review Panel for Diagnostics (ERPD).
The Global Fund continues to support countries to process requisitions efficiently and ensure products for the three diseases and COVID-19 are delivered as close to the promised dates as possible.